The utility of FRAX ® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study
ConclusionsFRAX ® enables a better assessment of major bone fracture risk in ESRD patients undergoing hemodialysis than any of its components and other risk factors considered in the analysis.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Calcium | Chronic Kidney Disease | Dialysis | Hemodialysis | Hormones | Orthopaedics | Osteoporosis | Poland Health | Statistics | Study | Urology & Nephrology